THT Biomaterials GmbH
THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. Developing a platform technology that will speed up research as it makes its results more realistic by replacing animal components with human components, makes them a one-of-a-kind company. They work closely with various academic institutions and pharmaceutical companies and already have over 30 publications and numerous citations to create personalized medicine for society.